Ask the KD Experts: Why is Kawasaki disease less commonly treated with steroids? While it’s not common for Rady Children’s Hospital to treat Kawasaki disease (KD) with steroids, the use of steroids in combination with IVIG continues to be...
Read More
**Your Input is Crucial! Help Shape a Toolkit for Pediatric Kawasaki Disease Patients Transitioning to Adult Cardiology Care** The KDF is reaching out to both youth and adult patients who are currently transitioning to adult healthcare or have successfully...
2024 Kawasaki Disease Parent Symposium Q&A Questions (Transcribed) Q: How can families participate in the KD genetic studies? Who qualifies to enroll and how? A: Currently, DNA studies are focused on patients with aneurysms. Families with a child who...
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association Kawasaki disease (KD) is an acute febrile illness mainly affecting children under 5 and is the leading cause of acquired heart disease in...
Editorial: Fostering Global Collaboration Around Kawasaki Disease. Reflections From the 14th International Kawasaki Disease Symposium From August 26 to August 29, the 14th International Kawasaki Disease Symposium (IKDS) was held in Montreal, Canada. For the past 40 years, IKDS...
Comparing Two Treatments for IVIG-Resistant Kawasaki Disease – Evidence Update for Clinicians Children with resistant KD who received infliximab were more likely to have their fever resolve within 24 hours than were children who received a second dose of...
Comparing Two Treatments for Resistant Kawasaki Disease – Evidence Update for Parents Compared with children who received a second dose of IVIG, children who received infliximab were more likely to have their fever end within 24 hours. Children who...
Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients and Caregivers The Kawasaki Disease Foundation teamed up with Kawasaki Disease Canada to host a symposium titled “Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients...
Control Participants Needed: individuals with no history of KD and who are not first relatives of someone with a history of KD The Kawasaki Disease Research Center at the University of California, San Diego, is looking for participants for...
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial Dr. Michael A. Portman and colleagues have published the results of a clinical trial showing benefits by etanercept (brand name Enbrel) for Kawasaki Disease patients. The results were...